•  
  •  
  •  
  •  

2025-10-06 13:27:03

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Swastika Investmart Launches 'Sarthi Trade Idea', India's First In-App Instant Trade Alerts
  • Ather Energy Crosses 5,00,000th Electric Scooter Production Milestone
  • Mann Fleet Partners Limited Files Draft Red Herring Prospectus with SEBI for Initial Public Offering
  • Airtel Business wins multi-year contract for the Indian Railway Security Operations Centre
  • RMC Switchgears Ltd achieves consolidated sales of Rs. 221 crores in H1FY2026

Keywords Selected:  Permission

Stock Report

  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Durvalumab Solution
  • AstraZeneca Pharma India Ltd receives permission for Olaparib film-coated tablets
  • Alfavision Overseas India Ltd updates on permission for harvesting of teakwood trees
  • AstraZeneca Pharma India Ltd receives permission to import new drug
  • Zydus receives approval from USFDA to initiate Phase II clinical trial of ZYIL1 in patients with Parkinson's disease
  • AstraZeneca Pharma India Ltd receives permission from CDSCO to import new drug
  • AstraZeneca Pharma India Ltd receives permission to Import pharmaceutical formulations of new drug for sale
  • AstraZeneca Pharma India receives permission to import Palivizumab solution for injection
  • Poonawalla Fincorp partners with IndusInd Bank for co-branded credit card, gets RBI permission
  • Som Distilleries and Breweries Ltd gets nod for supplying its beer brands in Chhattisgarh
  • NDTV gets nod for 4 new channels
  • Som Distilleries and Breweries Ltd's beer brands receives permission for supply to Rajasthan
  • AstraZeneca Pharma India Ltd receives permission for sale and distribution of Trastuzumab deruxtecan
  • KCL Infra Projects Ltd receives permission to uplink and downlink non News TV Channel
  • Tergene Biotech Pvt. Ltd receives SEC recommendation for pneumococcal 15 valent vaccine
  • AstraZeneca Pharma India receives permission for Dapagliflozin tablets
  • Balaji Amines completes Phase 1 of Greenfield Project
  • Federal Bank enables Utility Bill Payment Services in its Cross Border Remittance Platform
  • HIKAL restarts manufacturing at Taloja plant
  • Praveg Communications India Ltd receives permission for News and Current Affairs Satellite TV Channel
  • Kimia Biosciences Ltd gets permission for Bemopedoic acid bulk drug
  • CoSara Diagnostics gets permission from CDSCO for SARAQâ„¢ Hepatitis C Viral Load Kit as an IVD

Latest Post

  • Swastika Investmart Launches 'Sarthi Trade Idea', India's First In-App Instant Trade Alerts
  • Ather Energy Crosses 5,00,000th Electric Scooter Production Milestone
  • Mann Fleet Partners Limited Files Draft Red Herring Prospectus with SEBI for Initial Public Offering
  • Airtel Business wins multi-year contract for the Indian Railway Security Operations Centre
  • RMC Switchgears Ltd achieves consolidated sales of Rs. 221 crores in H1FY2026


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024